CIK 0000721371 · Large accelerated filer
CARDINAL HEALTH INC
Sign in to watch- Ticker
- CAH
- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Jun 30
- Incorporated
- OH
- Entity type
- operating
- EIN
- 310958666
- Phone
- 6147573033
- Business address
- 7000 CARDINAL PLACE, DUBLIN, OH, 43017
- Former names
- CARDINAL HEALTH INC, CARDINAL DISTRIBUTION INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $59,552,442
- in 7 filings
Net −$59,552,442. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Hollar Jason M. −$29.4M Chief Executive Officer sold 40% of stake
- Alt Aaron E −$9.9M Chief Financial Officer sold 67% of stake
- Mason Stephen M −$8.3M CEO, GMPD Segment sold 66% of stake
- Mayer Jessica L −$7.0M Chief Legal/Compliance Officer sold 47% of stake
- Greene Michelle D. −$2.7M Chief Information Officer sold 53% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-15 | Azelby Robert Director | Grant or award | +1,288 | 1,288 | ||
| 2024-02-15 | Alt Aaron E Chief Financial Officer | Shares withheld for taxes | −1,919 | $103.55 | $199K | 27,400 |
| 2024-02-15 | Greene Michelle D. Chief Information Officer | Shares withheld for taxes | −664 | $103.55 | $69K | 20,150 |
| 2023-12-01 | Snow Ola M Chief Human Resources Officer | Shares withheld for taxes | −382 | $107.08 | $41K | 24,842 |
| 2023-12-01 | Scherer Mary C. Chief Accounting Officer | Shares withheld for taxes | −217 | $107.08 | $23K | 10,432 |
| 2023-12-01 | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | Shares withheld for taxes | −638 | $107.08 | $68K | 34,564 |
| 2023-11-27 | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | Option exercise 10b5-1 | +5,990 | $84.27 | $505K | 50,192 |
| 2023-11-27 | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | Option exercise 10b5-1 | +6,279 | $83.19 | $522K | 56,471 |
| 2023-11-27 | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | Option exercise 10b5-1 | +15,373 | $66.43 | $1.0M | 71,844 |
| 2023-11-27 | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | Sale 10b5-1 | −36,642 | $106.31 | $3.9M | 35,202 |
| 2023-11-27 | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,990 | 0 | ||
| 2023-11-27 | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −6,279 | 0 | ||
| 2023-11-27 | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −15,373 | 0 | ||
| 2023-11-15 | Mayer Jessica L Chief Legal/Compliance Officer | Shares withheld for taxes | −5,185 | $102.90 | $534K | 79,680 |
| 2023-11-15 | Brennan Michelle Director | Grant or award | +1,965 | 5,289 | ||
| 2023-11-15 | Barg Steven Director | Grant or award | +1,965 | 4,739 | ||
| 2023-11-15 | Hall Patricia Hemingway Director | Grant or award | +1,965 | 29,467 | ||
| 2023-11-15 | Chandrasekaran Sujatha Director | Grant or award | +1,965 | 4,739 | ||
| 2023-11-15 | MUNDKUR CHRISTINE Director | Grant or award | +1,965 | 4,739 | ||
| 2023-11-15 | Killefer Nancy Director | Grant or award | +1,965 | 24,827 |
Page 11 of 24 · 478 trades